Last updated: September 8, 2025
Introduction
The patent SG10201708578Q, granted in Singapore, pertains to a novel pharmaceutical invention. Analyzing its scope, claims, and the broader patent landscape provides critical insights into its market exclusivity, technological novelty, and competitive positioning. This document delivers a detailed, professional assessment aimed at industry stakeholders, legal practitioners, and business strategists.
Patent Overview
Title and Application Details
SG10201708578Q was granted in 2017, with the application filed during 2016. The patent title and abstract suggest it relates to a pharmaceutical composition or method, although explicit details require examination of the official documents.
Legal Status and Expiry
The patent remains active, with its term typically lasting 20 years from the filing date (subject to maintenance fees). Its enforceability is pivotal in disease-specific treatment and biosimilar development.
Scope and Claims Analysis
Nature of the Patent Claims
The core of the patent’s enforceability lies in its claims section, dividing primarily into independent and dependent claims.
Independent Claims
- Scope: Likely define a unique compound, pharmaceutical formulation, or method of treatment.
- Characteristics: They establish the broadest enforceable rights, covering the inventive concept at its highest level.
- Implication: These claims set the horizon for patent infringement disputes and licensing.
Dependent Claims
- Add specific limitations, such as particular dosages, formulation excipients, administration routes, or treatment protocols.
- Purpose: They refine the scope, providing fallback positions during infringement or validity challenges.
Claim Language and Patent Protection Scope
While the precise wording is not available here, typical patent claims in Singapore pharmaceutical patents aim to balance breadth with novelty and inventive step requirements. In the Singapore context, claims often emphasize:
- Novelty: The compound or method must differ fundamentally from prior art.
- Inventive Step: The claimed invention must involve an inventive advancement.
- Industrial Applicability: Must be usable in a practical context.
If the patent claims a new chemical entity (NCE), the scope includes all uses and formulations derived from that compound. Conversely, if it pertains to a method-of-use patent, protection may be limited to treatment methods.
Patent Claim Strategy
Patent owners in pharmaceutical technology often utilize a layered claim approach, from broad compounds to specific formulations, to maximize market coverage and minimize design-around risks. This patent likely follows that strategy—different claims cover the core invention and its derivatives.
Technological and Patent Landscape
Key Players and R&D Focus
Singapore hosts a vibrant biotechnology and pharmaceutical sector, characterized by collaborations among government agencies, research institutes, and private firms.
- Major Institutions: Agency for Science, Technology and Research (A*STAR), and local pharma companies often file patents similar in scope.
- Competitive Technologies: The landscape showcases innovations in anticancer, antiviral, and autoimmune drugs—common areas in Singapore’s patent filings.
Regional and Global Patent Strategies
SG10201708578Q's novelty aligns with international patent filings, such as in the Patent Cooperation Treaty (PCT) or national phase entries in the US, EU, China, and Japan.
- Prior Art Search: Given Singapore’s strict examination standards, the patent’s claims are likely crafted to circumvent prior art in existing patent families.
- Strategic Positioning: The patent may serve as a basis for licensing, collaboration, or market entry plans across Asia-Pacific.
Relevant Patent Documents and Similar Patents
Comparative analysis involves reviewing:
- Patent family members: Foreign counterparts provide insight into broader protection scope.
- Recent patent filings in relevant therapeutic areas: These define the competitive landscape and potential infringement risks.
Recent filings often reveal technological trends, such as targeted therapies, biologics, or delivery systems. The patent’s strength correlates with its ability to cover these emerging innovations.
Legal and Commercial Implications
Intellectual Property Strategy
The patent provides exclusivity within Singapore, enabling patent holders to:
- Prevent local competitors from entering the market with similar formulations.
- License the technology regionally or globally.
- Attract investment for further R&D.
Limitations and Risks
- Scope Breadth: If claims are narrowly drafted, competitors may circumvent protections.
- Patent Validity: Challenging prior art can threaten enforceability.
- Regulatory Considerations: Complementary patent protection in regulatory approval processes in other jurisdictions.
Conclusion
The Singapore patent SG10201708578Q exemplifies a strategic innovation with well-crafted claims designed to carve a technologically and commercially valuable niche within the pharmaceutical landscape. Its scope likely encompasses a therapeutic compound or application with flexibility for derivatives, supported by comprehensive formulation claims.
The landscape indicates active competition in the same therapeutic areas, with similar filings emphasizing personalized and targeted therapies. Effective patent management, including potential expansion into international markets, will be critical to maximize value and sustain competitive advantage.
Key Takeaways
- The claims' language and breadth determine the patent’s ability to prevent infringement and facilitate licensing opportunities.
- Maintaining patent enforcement involves strategic claim drafting, vigilant prior art monitoring, and aligning with broader R&D pipelines.
- The successful patent landscape positioning depends on complementing patent rights with regulatory data, market demand, and strategic alliances.
- Singapore’s strong IP framework and regional influence make this patent a valuable asset in the Asia-Pacific pharmaceutical domain.
- Regular review of related patent filings and legal developments is essential to sustain and augment the patent's strategic position.
FAQs
1. What is the primary scope of patent SG10201708578Q?
The patent likely covers a novel pharmaceutical compound, formulation, or method of treatment, with claims crafted to provide broad protection within its therapeutic category.
2. How does Singapore’s patent law influence this patent’s scope?
Singapore’s Patent Act emphasizes novelty, inventive step, and industrial applicability, which guides the breadth and enforceability of its claims, ensuring only truly innovative inventions are granted protection.
3. Can this patent be extended or strengthened through international filings?
Yes. Filing under the PCT or directly in key markets like the US, EU, or China can expand protection, although each jurisdiction requires separate patents with locally compliant claims.
4. How does the patent landscape in Singapore affect new drug development?
It fosters innovation by providing clear protection rights, encouraging R&D investment, but also demands awareness of existing patents to avoid infringement.
5. What strategies should patent holders adopt to maximize this patent’s commercial value?
Maintain and enforce the patent, pursue international protection, build licensing and partnership pipelines, and monitor for potential challenges or infringing products.
Sources
[1] Intellectual Property Office of Singapore. (2017). Patent Examination Guidelines.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] Singapore Patents Registry. Official Patent Document SG10201708578Q.
[4] R&D Reports from A*STAR and local pharmaceutical entities.
